Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Government_Finance

Kaiser’s net income rose in 2021, operating income dipped

The decline in operating income was associated with an increase in care delivery costs linked to COVID-19.

February 14, 2022
Money Eye

Time to rethink how we compensate nonprofit hospital CEOs, think tank says

The average nonprofit hospital executive earns eight times more than their average hourly employee, experts with Brookline, Massachusetts-based Lown Institute reported.

February 11, 2022
Partnership

Strategic partnership: Press Ganey acquiring Forsta

The move will help Press Ganey, a healthcare-focused patient experience company, grow its technology offerings and expand globally.

February 10, 2022

Most physicians still paid based on volume, despite efforts to incentivize value-driven care

More than 80% of primary care physicians and 90% of specialists employed in group practices owned by health systems receive base pay under volume-driven models, new research shows.

January 31, 2022

Pharmacist gets 5 years in prison for $180M insurance fraud scam

David “Jason” Rutland paid kickbacks to distributors for prescription referrals that were medically unnecessary and illegally billed insurers.

January 27, 2022
business money suit investor

70% of healthcare executives expect M&A activity to ramp up this year

Many see labor shortages, supply chain issues and inflation as only modest obstacles to more deals.

January 26, 2022

Mark Cuban’s prescription drug company launches online pharmacy for affordable medications

The Mark Cuban Cost Plus Drug Company promises to bypass middlemen and "outrageous" markups for more than 100 medications.

January 19, 2022
Money

Insurers spent millions on ivermectin prescriptions for COVID-19, despite the drug being ineffective

Private and Medicare insurers spent nearly $2.5 million on the anti-parasite drug during a single week in August 2021, researchers reported in JAMA Network Open.

January 14, 2022

Around the web

Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.

U.S. physicians often receive payments from medical device manufacturers and pharmaceutical companies. New research in JAMA found a connection between receiving such payments and using specific devices—should the industry be concerned? 

Five of the largest U.S. medical societies focused on cardiovascular health are one step closer to seeing their paradigm-shifting proposal become a reality.

Trimed Popup
Trimed Popup